Clinical evaluation of somatostatin use in pancreatic resections: Clinical efficacy or limited benefit?

Surgery (United States)

Volumn 154, Issue 4, 2013, Pages 755-760

  Anderson, Ryan James ^a   Dunki Jacobs, Erik ^a   Callender, Glenda G ^a   Burnett, Nick ^a   Scoggins, Charles R ^a   McMasters, Kelly M ^a   Martin II, Robert C G ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOSTATIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DATA BASE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANCREAS FISTULA; PANCREAS RESECTION; PANCREAS SURGERY; PANCREATICODUODENECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATIC FISTULA; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; SOMATOSTATIN;

EID: 84884857975     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2013.07.001     Document Type: Article

References (33)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. M. Wagner, C. Redaelli, M. Lietz, C.A. Seiler, H. Friess, and M.W. Buchler Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma Br J Surg 91 2004 586 594
3. J.H. Balcom 4th, D.W. Rattner, A.L. Warshaw, Y. Chang, and C. Fernandez-del Castillo Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization Arch Surg 136 2001 391 398
4. N. Oneil Machado Pancreatic fistula after pancreatectomy: definitions, risk factors, preventive measures, and management-review Int J Surg Oncol 2012 2012 602478
5. R.S. Koti, K.S. Gurusamy, G. Fusai, and B.R. Davidson Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane review HPB 12 2010 155 165
6. C. Gouillat, J. Chipponi, J. Baulieux, C. Partensky, J. Saric, and B. Gayet Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy Br J Surg 88 2001 1456 1462
7. C.J. Yeo, J.L. Cameron, and K.D. Lillemoe Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial Ann Surg 232 2000 419 429
8. A.M. Lowy, J.E. Lee, and P.W. Pisters Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease Ann Surg 226 1997 632 641
9. C. Bassi, C. Dervenis, and G. Butturini Postoperative pancreatic fistula: an international study group (ISGPF) definition Surgery 138 2005 8 13
10. M.P. Callery, W.B. Pratt, and C.M. Vollmer Jr. Prevention and management of pancreatic fistula J Gastrointest Surg 13 2009 163 173
11. S.V. Shrikhande, and M.A. D'Souza Pancreatic fistula after pancreatectomy: evolving definitions, preventive strategies and modern management World J Gastroenterol 14 2008 5789 5796
12. E.C. Lai, S.H. Lau, and W.Y. Lau Measures to prevent pancreatic fistula after pancreatoduodenectomy: a comprehensive review Arch Surg 144 2009 1074 1080
13. M.G. Sarr The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial J Am Coll Surg 196 2003 556 564
14. Y.S. Shan, E.D. Sy, and P.W. Lin Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomized, controlled trial World J Surg 27 2003 709 714
15. B. Suc, S. Msika, and M. Piccinini Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial Arch Surg 139 2004 288 294
16. U.J. Hesse, C. DeDecker, and P. Houtmeyers Prospectively randomized trial using perioperative low-dose octreotide to prevent organ-related and general complications after pancreatic surgery and pancreatico-jejunostomy World J Surg 29 2005 1325 1328
17. P.D. Subhedar, S.H. Patel, and P.J. Kneuertz Risk factors for pancreatic fistula after stapled gland transection Am Surg 77 2011 965 970
18. M.A. D'Souza, and S.V. Shrikhande Pancreatic resectional surgery: an evidence-based perspective J Cancer Res Ther 4 2008 77 83
19. N. Alexakis, C. Halloran, M. Raraty, P. Ghaneh, R. Sutton, and J.P. Neoptolemos Current standards of surgery for pancreatic cancer Br J Surg 91 2004 1410 1427
20. S. Connor, N. Alexakis, O.J. Garden, E. Leandros, J. Bramis, and S.J. Wigmore Meta-analysis of the value of somatostatin and its analogues in reducing complications associated with pancreatic surgery Br J Surg 92 2005 1059 1067
21. M.Z.M. Montorsi, F. Mosca, L. Capussotti, E. Zotti, G. Ribotta, and G. Fegiz Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial Surgery 117 1995 26 31
22. A.A. Alghamdi, A.M. Jawas, and R.S. Hart Use of octreotide for the prevention of pancreatic fistula after elective pancreatic surgery: a systematic review and meta-analysis Can J Surg 50 2007 459 466
23. J.J. Mezhir Management of complications following pancreatic resection: An evidence-based approach J Surg Oncol 107 2013 58 66
24. C.M. Schmidt, E.S. Powell, and C.T. Yiannoutsos Pancreaticoduodenectomy: a 20-year experience in 516 patients Arch Surg 139 2004 718 725
25. A.M. Fox, K. Pitzul, and F. Bhojani Comparison of outcomes and costs between laparoscopic distal pancreatectomy and open resection at a single center Surg Endosc 26 2012 1220 1230
26. B. Sepesi, J. Moalem, E. Galka, P. Salzman, and L.O. Schoeniger The influence of staple size on fistula formation following distal pancreatectomy J Gastrointest Surg 16 2012 267 274
27. J.A. Blansfield, M.M. Rapp, and R.J. Chokshi Novel method of stump closure for distal pancreatectomy with a 75% reduction in pancreatic fistula rate J Gastrointest Surg 16 2012 524 528
28. I. Klempa, U. Schwedes, and K.H. Usadel [Prevention of postoperative pancreatic complications following duodenopancreatectomy using somatostatin] Der Chirurg 50 1979 427 431
29. J.L. Cameron, T.S. Riall, J. Coleman, and K.A. Belcher One thousand consecutive pancreaticoduodenectomies Ann Surg 244 2006 10 15
30. K.E. Gyr, and R. Meier Pharmacodynamic effects of Sandostatin in the gastrointestinal tract Metabolism: clinical and experimental 41 9 Suppl 2 1992 17 21
31. E. Kohler, C. Beglinger, S. Dettwiler, I. Whitehouse, and K. Gyr Effect of a new somatostatin analogue on pancreatic function in healthy volunteers Pancreas 1 1986 154 159
32. W. Bauer, U. Briner, and W. Doepfner SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action Life Sci 31 1982 1133 1140
33. S.R. Grobmyer, D. Kooby, L.H. Blumgart, and S.N. Hochwald Novel pancreaticojejunostomy with a low rate of anastomotic failure-related complications J Am Coll Surg 210 2010 54 59